Lin SH, Wu JL, Tsai YN, Tseng CH, et al. Comparative Effectiveness and Safety of Atezolizumab-Bevacizumab and Durvalumab-Tremelimumab as First-Line Systemic Therapy for Hepatocellular Carcinoma: A Real-World Study. J Gastroenterol Hepatol 2026 Jul 10. doi: 10.1111/jgh.70555.
PMID: 42432450